Literature DB >> 1430011

Determination of vinorelbine (Navelbine) in tumour cells by high-performance liquid chromatography.

V Debal1, H Morjani, J M Millot, J F Angiboust, B Gourdier, M Manfait.   

Abstract

A high-performance liquid chromatographic method has been developed for the determination within tumour cells of a new vinca alkaloid, vinorelbine. Extractions of vinorelbine from cells were carried out using absolute ethanol. The extracts were injected into a reversed-phase system consisting of two Novapak C18 columns connected in series. The mobile phase was acetonitrile-phosphate buffer, pH 2.7 (60:40, v/v). Using a fluorescence detection, the limit of determination was 8 pmol injected. This method would be suitable for studying the cellular pharmacokinetics of vinorelbine in patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1430011     DOI: 10.1016/0378-4347(92)80451-u

Source DB:  PubMed          Journal:  J Chromatogr


  7 in total

Review 1.  Clinical pharmacokinetics of vinorelbine.

Authors:  D Levêque; F Jehl
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

Review 2.  Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.

Authors:  K L Goa; D Faulds
Journal:  Drugs Aging       Date:  1994-09       Impact factor: 3.923

3.  Expression of mdr1 gene in human breast primary tumors and metastases.

Authors:  E Hennequin; C Delvincourt; C Pourny; J C Jardillier
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

4.  A new lipid-based nano formulation of vinorelbine.

Authors:  Fatemeh Bahadori; Gülaçtı Topçu; Mehmet S Eroğlu; Hayat Onyüksel
Journal:  AAPS PharmSciTech       Date:  2014-05-29       Impact factor: 3.246

5.  Structure-activity relationships for xenobiotic transport substrates and inhibitory ligands of P-glycoprotein.

Authors:  L J Bain; J B McLachlan; G A LeBlanc
Journal:  Environ Health Perspect       Date:  1997-08       Impact factor: 9.031

Review 6.  Vinorelbine--a clinical review.

Authors:  R K Gregory; I E Smith
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

7.  Characterisation of a navelbine-resistant bladder carcinoma cell line cross-resistant to taxoids.

Authors:  V Debal; N Allam; H Morjani; J M Millot; D Braguer; F Breillout; M Manfait
Journal:  Br J Cancer       Date:  1994-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.